Search research articles
Contact Us
Filters
Showing results (91-100 of 148) with videos related to
Page
of 15
Sort By:
Annals of Clinical and Translational Neurology
|
May 15, 2021
No strong HLA association with MOG antibody disease in the UK population
Melissa Grant-Peters, Giordani Rodrigues Dos Passos, Hing-Yuen Yeung, et al.
Case Reports in Neurology
|
September 2, 2015
Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy
Besa Ziso, Tim L Williams, R Jon L Walters, et al.
Multiple Sclerosis and Related Disorders
|
September 20, 2025
Post marketing real-world experience of ravulizumab in NMOSD
Anu Jacob, Azza Mahmoud, Rami R Saab, et al.
Plos One
|
May 22, 2026
Retinal macrophage-like cell activation and ganglion cell layer thinning are associated with disability and MRI lesion burden in multiple sclerosis
Francesco Pichi, Yanny Perez Jimenez, Matteo Belletti, et al.
BMC Pulmonary Medicine
|
August 2, 2020
Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report
Jake E Cowen, James Stevenson, Madhusudan Paravasthu, et al.
Aesthetic Plastic Surgery
|
November 15, 2024
Comparative Analysis of Cellulite Treatment Modalities: A Systematic Review
Su Kwan Lim, Gozde Gultekin, Srutti Suresan, et al.
Archives of Neurology
|
September 16, 2009
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients
Anu Jacob, Marcelo Matiello, Brian G Weinshenker, et al.
Practical Neurology
|
December 1, 2018
Rituximab in neurological disease: principles, evidence and practice
Daniel H Whittam, Emma C Tallantyre, Stephen Jolles, et al.
BMJ Open
|
December 1, 2021
Predictors of relapse in MOG antibody associated disease: a cohort study
Saif Huda, Daniel Whittam, Richard Jackson, et al.
Multiple Sclerosis and Related Disorders
|
August 23, 2025
Efficacy and safety of ocrelizumab in pediatric multiple sclerosis
Ahmad Altelly, Azza Mahmoud, Victoria Mifsud, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 148) with videos related to
Sort By:
Page
of 15
Annals of Clinical and Translational Neurology
|
May 15, 2021
No strong HLA association with MOG antibody disease in the UK population
Melissa Grant-Peters, Giordani Rodrigues Dos Passos, Hing-Yuen Yeung, et al.
Case Reports in Neurology
|
September 2, 2015
Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy
Besa Ziso, Tim L Williams, R Jon L Walters, et al.
Multiple Sclerosis and Related Disorders
|
September 20, 2025
Post marketing real-world experience of ravulizumab in NMOSD
Anu Jacob, Azza Mahmoud, Rami R Saab, et al.
Plos One
|
May 22, 2026
Retinal macrophage-like cell activation and ganglion cell layer thinning are associated with disability and MRI lesion burden in multiple sclerosis
Francesco Pichi, Yanny Perez Jimenez, Matteo Belletti, et al.
BMC Pulmonary Medicine
|
August 2, 2020
Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report
Jake E Cowen, James Stevenson, Madhusudan Paravasthu, et al.
Aesthetic Plastic Surgery
|
November 15, 2024
Comparative Analysis of Cellulite Treatment Modalities: A Systematic Review
Su Kwan Lim, Gozde Gultekin, Srutti Suresan, et al.
Archives of Neurology
|
September 16, 2009
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients
Anu Jacob, Marcelo Matiello, Brian G Weinshenker, et al.
Practical Neurology
|
December 1, 2018
Rituximab in neurological disease: principles, evidence and practice
Daniel H Whittam, Emma C Tallantyre, Stephen Jolles, et al.
BMJ Open
|
December 1, 2021
Predictors of relapse in MOG antibody associated disease: a cohort study
Saif Huda, Daniel Whittam, Richard Jackson, et al.
Multiple Sclerosis and Related Disorders
|
August 23, 2025
Efficacy and safety of ocrelizumab in pediatric multiple sclerosis
Ahmad Altelly, Azza Mahmoud, Victoria Mifsud, et al.
Page
of 15